cannabis investing Cardiol Therapeutics to Present at Canaccord Genuity 39th Annual Growth Conference
cannabis investing Cardiol Therapeutics Announces Plans for Orphan Drug Program in Acute Myocarditis with CardiolRx CBD Formulation
cannabis investing Cardiol Therapeutics’ Pharmaceutical Partner Noramco Presents at U.S. FDA Public Hearing on CBD
pharmaceutical investing Cardiol Therapeutics: A Leader in Research and Commercial Development of Pharmaceutical Cannabidiol Products and Targeted Therapies for Heart Failure and Cancer
cannabis investing Cardiol Therapeutics Completes Initial Public Offering and the Company’s Common Shares and Warrants Commence Trading on the Toronto Stock Exchange Under the Symbols “CRDL” and “CRDL.WT”
Standard Uranium Executes Letter of Intent to Option Rocas Uranium Project in Eastern Athabasca Basin
NevGold Announces Updated Open-Pit, Heap-Leach Gold Mineral Resource Including 1,186,000 ozs Indicated and 548,000 ozs Inferred At Nutmeg Mountain in Idaho
Sun Summit Strengthens Cu-Au Porphyry Potential at the JD Project, Toodoggone District: Defines an Open-Ended 8.5 km Long IP Anomaly
